$AGTC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in APPLIED GENETIC TECHNOLOGIES CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in APPLIED GENETIC TECHNOLOGIES CORP. Get notifications about new insider transactions in APPLIED GENETIC TECHNOLOGIES CORP for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18 2020 | AGTC | APPLIED GENETIC TE ... | VANLENT ANNE | Director | Option Exercise | A | 4.72 | 12,000 | 56,640 | 12,000 | |
| Dec 18 2020 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Option Exercise | A | 4.72 | 12,000 | 56,640 | 12,000 | |
| Dec 18 2020 | AGTC | APPLIED GENETIC TE ... | Magovcevic-Liebisch Ivana | Director | Option Exercise | A | 4.72 | 12,000 | 56,640 | 12,000 | |
| Dec 18 2020 | AGTC | APPLIED GENETIC TE ... | HURWITZ EDWARD | Director | Option Exercise | A | 4.72 | 12,000 | 56,640 | 12,000 | |
| Dec 18 2020 | AGTC | APPLIED GENETIC TE ... | Aliski William | Director | Option Exercise | A | 4.72 | 12,000 | 56,640 | 12,000 | |
| Dec 18 2020 | AGTC | APPLIED GENETIC TE ... | Koenig Scott | Director | Option Exercise | A | 4.72 | 12,000 | 56,640 | 12,000 | |
| Aug 18 2020 | AGTC | APPLIED GENETIC TE ... | Potter Stephen W | VP and Chief Busine ... | Payment of Exercise | F | 5.77 | 5,723 | 33,022 | 34,677 | 40.4 K to 34.7 K (-14.17 %) |
| Aug 18 2020 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Payment of Exercise | F | 5.77 | 5,723 | 33,022 | 33,277 | 39 K to 33.3 K (-14.67 %) |
| Aug 07 2020 | AGTC | APPLIED GENETIC TE ... | Potter Stephen W | VP and Chief Busine ... | Option Exercise | A | 5.50 | 50,000 | 275,000 | 50,000 | |
| Aug 07 2020 | AGTC | APPLIED GENETIC TE ... | Sullivan William A. | Chief Financial Off ... | Option Exercise | A | 5.50 | 50,000 | 275,000 | 50,000 | |
| Aug 07 2020 | AGTC | APPLIED GENETIC TE ... | Washer Susan B. | President and CEO | Option Exercise | A | 5.50 | 169,000 | 929,500 | 169,000 | |
| Aug 07 2020 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Option Exercise | A | 5.50 | 50,000 | 275,000 | 50,000 | |
| Dec 30 2019 | AGTC | APPLIED GENETIC TE ... | Krol Patrick Johan Hendrik | 10% Owner | Sell | S | 5.24 | 81,162 | 425,289 | 1,780,762 | 1.9 M to 1.8 M (-4.36 %) |
| Dec 06 2019 | AGTC | APPLIED GENETIC TE ... | VANLENT ANNE | Director | Option Exercise | A | 3.02 | 10,000 | 30,200 | 10,000 | |
| Dec 06 2019 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Option Exercise | A | 3.02 | 10,000 | 30,200 | 10,000 | |
| Dec 06 2019 | AGTC | APPLIED GENETIC TE ... | Magovcevic Ivana | Director | Option Exercise | A | 3.02 | 10,000 | 30,200 | 10,000 | |
| Dec 06 2019 | AGTC | APPLIED GENETIC TE ... | HURWITZ EDWARD | Director | Option Exercise | A | 3.02 | 10,000 | 30,200 | 10,000 | |
| Dec 06 2019 | AGTC | APPLIED GENETIC TE ... | Aliski William | Director | Option Exercise | A | 3.02 | 10,000 | 30,200 | 10,000 | |
| Dec 06 2019 | AGTC | APPLIED GENETIC TE ... | Koenig Scott | Director | Option Exercise | A | 3.02 | 10,000 | 30,200 | 10,000 | |
| Nov 26 2019 | AGTC | APPLIED GENETIC TE ... | Krol Patrick Johan Hendrik | 10% Owner | Buy | P | 2.79 | 2,544 | 7,098 | 1,861,924 | 1.9 M to 1.9 M (+0.14 %) |
| Sep 20 2019 | AGTC | APPLIED GENETIC TE ... | Washer Susan B. | President and CEO | Option Exercise | M | 3.50 | 5,700 | 19,950 | 13,841 | |
| Sep 20 2019 | AGTC | APPLIED GENETIC TE ... | Washer Susan B. | President and CEO | Buy | M | 3.50 | 5,700 | 19,950 | 28,408 | 22.7 K to 28.4 K (+25.10 %) |
| Aug 19 2019 | AGTC | APPLIED GENETIC TE ... | Krex Brian | General Counsel | Option Exercise | A | 3.00 | 13,000 | 39,000 | 13,000 | |
| Aug 19 2019 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Option Exercise | A | 3.00 | 52,000 | 156,000 | 52,000 | |
| Aug 19 2019 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Grant | A | 0.00 | 39,000 | 0 | 39,000 | 0 to 39 K |
| Aug 19 2019 | AGTC | APPLIED GENETIC TE ... | Potter Stephen W | VP and Chief Busine ... | Option Exercise | A | 3.00 | 52,000 | 156,000 | 52,000 | |
| Aug 19 2019 | AGTC | APPLIED GENETIC TE ... | Potter Stephen W | VP and Chief Busine ... | Grant | A | 0.00 | 39,000 | 0 | 40,400 | 1.4 K to 40.4 K (+2,785.71 %) |
| Aug 19 2019 | AGTC | APPLIED GENETIC TE ... | Sullivan William A. | Chief Financial Off ... | Option Exercise | A | 3.00 | 52,000 | 156,000 | 52,000 | |
| Aug 19 2019 | AGTC | APPLIED GENETIC TE ... | Washer Susan B. | President and CEO | Option Exercise | A | 3.00 | 100,000 | 300,000 | 100,000 | |
| Jul 31 2019 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Exec. VP, Global St ... | Option Exercise | A | 3.91 | 100,000 | 391,000 | 100,000 | |
| Jul 31 2019 | AGTC | APPLIED GENETIC TE ... | Heah Theresa | Chief Medical Offic ... | Option Exercise | A | 3.91 | 100,000 | 391,000 | 100,000 | |
| Jul 31 2019 | AGTC | APPLIED GENETIC TE ... | Heah Theresa | Chief Medical Offic ... | Option Exercise | A | 3.91 | 100,000 | 391,000 | 100,000 | |
| Jul 15 2019 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Payment of Exercise | F | 3.75 | 592 | 2,220 | 56,052 | 56.6 K to 56.1 K (-1.05 %) |
| Jul 15 2019 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Grant | A | 0.00 | 2,000 | 0 | 56,644 | 54.6 K to 56.6 K (+3.66 %) |
| Jun 13 2019 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Payment of Exercise | F | 3.77 | 685 | 2,582 | 54,644 | 55.3 K to 54.6 K (-1.24 %) |
| Jun 13 2019 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Grant | A | 0.00 | 2,000 | 0 | 55,329 | 53.3 K to 55.3 K (+3.75 %) |
| May 30 2019 | AGTC | APPLIED GENETIC TE ... | Koenig Scott | Director | Option Exercise | M | 0.35 | 32,018 | 11,206 | 0 | |
| May 30 2019 | AGTC | APPLIED GENETIC TE ... | Koenig Scott | Director | Buy | M | 0.35 | 32,018 | 11,206 | 34,246 | 2.2 K to 34.2 K (+1,437.07 %) |
| May 15 2019 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Payment of Exercise | F | 4.20 | 685 | 2,877 | 53,329 | 54 K to 53.3 K (-1.27 %) |
| May 15 2019 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Grant | A | 0.00 | 2,000 | 0 | 54,014 | 52 K to 54 K (+3.85 %) |
| Apr 18 2019 | AGTC | APPLIED GENETIC TE ... | Krex Brian | General Counsel | Option Exercise | A | 4.20 | 125,000 | 525,000 | 125,000 | |
| Apr 15 2019 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Payment of Exercise | F | 4.61 | 606 | 2,794 | 52,014 | 52.6 K to 52 K (-1.15 %) |
| Apr 15 2019 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Grant | A | 0.00 | 2,000 | 0 | 52,620 | 50.6 K to 52.6 K (+3.95 %) |
| Mar 13 2019 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Payment of Exercise | F | 3.97 | 667 | 2,648 | 50,620 | 51.3 K to 50.6 K (-1.30 %) |
| Mar 13 2019 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Grant | A | 0.00 | 2,000 | 0 | 51,287 | 49.3 K to 51.3 K (+4.06 %) |
| Feb 13 2019 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Payment of Exercise | F | 3.29 | 791 | 2,602 | 49,287 | 50.1 K to 49.3 K (-1.58 %) |
| Feb 13 2019 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Grant | A | 0.00 | 2,000 | 0 | 50,078 | 48.1 K to 50.1 K (+4.16 %) |
| Jan 15 2019 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Payment of Exercise | F | 3.20 | 713 | 2,282 | 48,078 | 48.8 K to 48.1 K (-1.46 %) |
| Jan 15 2019 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Grant | A | 0.00 | 2,000 | 0 | 48,791 | 46.8 K to 48.8 K (+4.27 %) |
| Dec 18 2018 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Buy | P | 3.38 | 1,000 | 3,381 | 1,000 | 0 to 1,000 |
| Dec 18 2018 | AGTC | APPLIED GENETIC TE ... | Aliski William | Director | Buy | P | 3.24 | 500 | 1,620 | 8,500 | 8 K to 8.5 K (+6.25 %) |
| Dec 18 2018 | AGTC | APPLIED GENETIC TE ... | Aliski William | Director | Buy | P | 3.25 | 4,300 | 13,975 | 8,000 | 3.7 K to 8 K (+116.22 %) |
| Dec 18 2018 | AGTC | APPLIED GENETIC TE ... | Aliski William | Director | Buy | P | 3.24 | 1,200 | 3,882 | 3,700 | 2.5 K to 3.7 K (+48.00 %) |
| Dec 18 2018 | AGTC | APPLIED GENETIC TE ... | Sullivan William A. | Chief Financial Off ... | Buy | P | 3.33 | 3,000 | 9,990 | 3,000 | 0 to 3 K |
| Dec 18 2018 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Sell | S | 3.35 | 3,000 | 10,053 | 0 | 3 K to 0 (-100.00 %) |
| Dec 18 2018 | AGTC | APPLIED GENETIC TE ... | Washer Susan B. | President and CEO | Buy | P | 3.34 | 2,380 | 7,949 | 22,708 | 20.3 K to 22.7 K (+11.71 %) |
| Dec 13 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Payment of Exercise | F | 6.11 | 611 | 3,733 | 46,791 | 47.4 K to 46.8 K (-1.29 %) |
| Dec 13 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Grant | A | 0.00 | 2,000 | 0 | 47,402 | 45.4 K to 47.4 K (+4.41 %) |
| Dec 13 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Payment of Exercise | F | 6.11 | 611 | 3,733 | 46,791 | 47.4 K to 46.8 K (-1.29 %) |
| Dec 13 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Grant | A | 0.00 | 2,000 | 0 | 47,402 | 45.4 K to 47.4 K (+4.41 %) |
| Nov 19 2018 | AGTC | APPLIED GENETIC TE ... | VANLENT ANNE | Director | Option Exercise | A | 6.90 | 10,000 | 69,000 | 10,000 | |
| Nov 19 2018 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Option Exercise | A | 6.90 | 10,000 | 69,000 | 10,000 | |
| Nov 19 2018 | AGTC | APPLIED GENETIC TE ... | Magovcevic Ivana | Director | Option Exercise | A | 6.90 | 10,000 | 69,000 | 10,000 | |
| Nov 19 2018 | AGTC | APPLIED GENETIC TE ... | HURWITZ EDWARD | Director | Option Exercise | A | 6.90 | 10,000 | 69,000 | 10,000 | |
| Nov 19 2018 | AGTC | APPLIED GENETIC TE ... | Aliski William | Director | Option Exercise | A | 6.90 | 10,000 | 69,000 | 10,000 | |
| Nov 19 2018 | AGTC | APPLIED GENETIC TE ... | Koenig Scott | Director | Option Exercise | A | 6.90 | 10,000 | 69,000 | 10,000 | |
| Oct 15 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Payment of Exercise | F | 6.46 | 612 | 3,954 | 44,087 | 44.7 K to 44.1 K (-1.37 %) |
| Oct 15 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Payment of Exercise | F | 6.46 | 612 | 3,954 | 44,087 | 44.7 K to 44.1 K (-1.37 %) |
| Oct 15 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Grant | A | 0.00 | 2,000 | 0 | 44,699 | 42.7 K to 44.7 K (+4.68 %) |
| Oct 15 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Grant | A | 0.00 | 2,000 | 0 | 44,699 | 42.7 K to 44.7 K (+4.68 %) |
| Sep 24 2018 | AGTC | APPLIED GENETIC TE ... | Aliski William | Director | Option Exercise | A | 4.40 | 25,000 | 110,000 | 25,000 | |
| Sep 13 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Payment of Exercise | F | 3.93 | 685 | 2,689 | 42,699 | 43.4 K to 42.7 K (-1.58 %) |
| Sep 13 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Grant | A | 0.00 | 2,000 | 0 | 43,384 | 41.4 K to 43.4 K (+4.83 %) |
| Aug 15 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Payment of Exercise | F | 4.00 | 592 | 2,368 | 41,384 | 42 K to 41.4 K (-1.41 %) |
| Aug 15 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Grant | A | 0.00 | 2,000 | 0 | 41,976 | 40 K to 42 K (+5.00 %) |
| Jul 27 2018 | AGTC | APPLIED GENETIC TE ... | VANLENT ANNE | Director | Option Exercise | A | 4.25 | 8,000 | 34,000 | 8,000 | |
| Jul 27 2018 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Option Exercise | A | 4.25 | 8,000 | 34,000 | 8,000 | |
| Jul 27 2018 | AGTC | APPLIED GENETIC TE ... | Magovcevic Ivana | Director | Option Exercise | A | 4.25 | 8,000 | 34,000 | 8,000 | |
| Jul 27 2018 | AGTC | APPLIED GENETIC TE ... | HURWITZ EDWARD | Director | Option Exercise | A | 4.25 | 8,000 | 34,000 | 8,000 | |
| Jul 27 2018 | AGTC | APPLIED GENETIC TE ... | Koenig Scott | Director | Option Exercise | A | 4.25 | 8,000 | 34,000 | 8,000 | |
| Jul 27 2018 | AGTC | APPLIED GENETIC TE ... | Potter Stephen W | VP and Chief Busine ... | Option Exercise | A | 4.25 | 85,000 | 361,250 | 85,000 | |
| Jul 27 2018 | AGTC | APPLIED GENETIC TE ... | Sullivan William A. | Chief Financial Off ... | Option Exercise | A | 4.25 | 60,000 | 255,000 | 60,000 | |
| Jul 27 2018 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Option Exercise | A | 4.25 | 85,000 | 361,250 | 85,000 | |
| Jul 27 2018 | AGTC | APPLIED GENETIC TE ... | Washer Susan B. | President and CEO | Option Exercise | A | 4.25 | 100,000 | 425,000 | 100,000 | |
| Jul 13 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Payment of Exercise | F | 4.15 | 685 | 2,843 | 39,976 | 40.7 K to 40 K (-1.68 %) |
| Jul 13 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Grant | A | 0.00 | 2,000 | 0 | 40,661 | 38.7 K to 40.7 K (+5.17 %) |
| Jun 13 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Payment of Exercise | F | 4.55 | 606 | 2,757 | 38,661 | 39.3 K to 38.7 K (-1.54 %) |
| Jun 13 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Grant | A | 0.00 | 2,000 | 0 | 39,267 | 37.3 K to 39.3 K (+5.37 %) |
| May 29 2018 | AGTC | APPLIED GENETIC TE ... | HURWITZ EDWARD | Director | Buy | J | 0.00 | 25,672 | 0 | 27,472 | 1.8 K to 27.5 K (+1,426.22 %) |
| May 18 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Payment of Exercise | F | 5.60 | 3,425 | 19,180 | 37,267 | 40.7 K to 37.3 K (-8.42 %) |
| Apr 13 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Payment of Exercise | F | 4.00 | 685 | 2,740 | 39,377 | 40.1 K to 39.4 K (-1.71 %) |
| Apr 13 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Grant | A | 0.00 | 2,000 | 0 | 40,062 | 38.1 K to 40.1 K (+5.25 %) |
| Apr 06 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Payment of Exercise | F | 3.75 | 3,395 | 12,731 | 24,253 | 27.6 K to 24.3 K (-12.28 %) |
| Mar 30 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Grant | A | 0.00 | 10,000 | 0 | 42,126 | 32.1 K to 42.1 K (+31.13 %) |
| Mar 14 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Payment of Exercise | F | 4.30 | 667 | 2,868 | 32,126 | 32.8 K to 32.1 K (-2.03 %) |
| Mar 14 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Grant | A | 0.00 | 2,000 | 0 | 32,793 | 30.8 K to 32.8 K (+6.49 %) |
| Feb 13 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Grant | A | 0.00 | 2,000 | 0 | 30,793 | 28.8 K to 30.8 K (+6.95 %) |
| Jan 16 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Payment of Exercise | F | 4.30 | 855 | 3,677 | 28,793 | 29.6 K to 28.8 K (-2.88 %) |
| Jan 16 2018 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Grant | A | 0.00 | 2,000 | 0 | 29,648 | 27.6 K to 29.6 K (+7.23 %) |
| Sep 15 2017 | AGTC | APPLIED GENETIC TE ... | Feinsod Matthew | Interim Chief Medic ... | Grant | A | 0.00 | 10,000 | 0 | 27,648 | 17.6 K to 27.6 K (+56.66 %) |
| Aug 09 2017 | AGTC | APPLIED GENETIC TE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Option Exercise | A | 4.50 | 4,168 | 18,756 | 4,168 | |
| Aug 09 2017 | AGTC | APPLIED GENETIC TE ... | Sullivan William A. | Chief Financial Off ... | Option Exercise | A | 5.00 | 135,000 | 675,000 | 135,000 | |
| Aug 03 2017 | AGTC | APPLIED GENETIC TE ... | Ashe Andrew D. | General Counsel | Option Exercise | A | 4.60 | 100,000 | 460,000 | 100,000 | |
| Jul 18 2017 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Option Exercise | A | 4.90 | 50,000 | 245,000 | 50,000 | |
| Jul 18 2017 | AGTC | APPLIED GENETIC TE ... | Goldstein Michael H. | Chief Medical Offic ... | Option Exercise | A | 4.90 | 25,000 | 122,500 | 25,000 | |
| Jul 18 2017 | AGTC | APPLIED GENETIC TE ... | Washer Susan B. | President and CEO | Option Exercise | A | 4.90 | 100,000 | 490,000 | 100,000 | |
| Jul 18 2017 | AGTC | APPLIED GENETIC TE ... | Potter Stephen W | See Remarks | Option Exercise | A | 4.90 | 50,000 | 245,000 | 50,000 | |
| Apr 26 2017 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Option Exercise | X | 4.54 | 91 | 413 | 0 | |
| Apr 26 2017 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Option Exercise | X | 4.54 | 328 | 1,489 | 0 | |
| Apr 26 2017 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Option Exercise | X | 4.54 | 11,476 | 52,095 | 0 | |
| Apr 26 2017 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Buy | X | 0.00 | 28 | 0 | 11,208 | 11.2 K to 11.2 K (+0.25 %) |
| Apr 26 2017 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Buy | X | 0.00 | 101 | 0 | 40,181 | 40.1 K to 40.2 K (+0.25 %) |
| Apr 26 2017 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Buy | X | 0.00 | 3,559 | 0 | 1,404,515 | 1.4 M to 1.4 M (+0.25 %) |
| Mar 02 2017 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Option Exercise | A | 7.75 | 8,000 | 62,000 | 8,000 | |
| Mar 02 2017 | AGTC | APPLIED GENETIC TE ... | HURWITZ EDWARD | Director | Option Exercise | A | 7.75 | 8,000 | 62,000 | 8,000 | |
| Mar 02 2017 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Option Exercise | A | 7.75 | 8,000 | 62,000 | 8,000 | |
| Mar 02 2017 | AGTC | APPLIED GENETIC TE ... | VANLENT ANNE | Director | Option Exercise | A | 7.75 | 8,000 | 62,000 | 8,000 | |
| Mar 02 2017 | AGTC | APPLIED GENETIC TE ... | Magovcevic Ivana | Director | Option Exercise | A | 7.75 | 8,000 | 62,000 | 8,000 | |
| Mar 02 2017 | AGTC | APPLIED GENETIC TE ... | Koenig Scott | Director | Option Exercise | A | 7.75 | 8,000 | 62,000 | 8,000 | |
| Dec 02 2016 | AGTC | APPLIED GENETIC TE ... | Goldstein Michael H. | Chief Medical Offic ... | Option Exercise | A | 8.70 | 180,000 | 1,566,000 | 180,000 | |
| Nov 17 2016 | AGTC | APPLIED GENETIC TE ... | Magovcevic Ivana | Director | Buy | P | 9.63 | 3,000 | 28,875 | 3,000 | 0 to 3 K |
| Nov 02 2016 | AGTC | APPLIED GENETIC TE ... | Chulay Jeffrey D. | VP and Chief Medica ... | Sell | S | 7.05 | 1,000 | 7,052 | 20,400 | 21.4 K to 20.4 K (-4.67 %) |
| Oct 21 2016 | AGTC | APPLIED GENETIC TE ... | Chulay Jeffrey D. | VP and Chief Medica ... | Option Exercise | M | 0.35 | 1,000 | 350 | 29,511 | |
| Oct 21 2016 | AGTC | APPLIED GENETIC TE ... | Chulay Jeffrey D. | VP and Chief Medica ... | Buy | M | 0.35 | 1,000 | 350 | 12,400 | 11.4 K to 12.4 K (+8.77 %) |
| Oct 21 2016 | AGTC | APPLIED GENETIC TE ... | Chulay Jeffrey D. | VP and Chief Medica ... | Gift | G | 0.00 | 500 | 0 | 11,400 | 11.9 K to 11.4 K (-4.20 %) |
| Sep 27 2016 | AGTC | APPLIED GENETIC TE ... | Potter Stephen W | See Remarks | Buy | P | 8.69 | 400 | 3,476 | 1,400 | 1,000 to 1.4 K (+40.00 %) |
| Sep 27 2016 | AGTC | APPLIED GENETIC TE ... | Potter Stephen W | See Remarks | Buy | P | 8.97 | 1,000 | 8,970 | 1,000 | 0 to 1,000 |
| Sep 26 2016 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Buy | P | 8.87 | 1,300 | 11,531 | 3,000 | 1.7 K to 3 K (+76.47 %) |
| Sep 26 2016 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Buy | P | 8.87 | 1,700 | 15,071 | 1,700 | 0 to 1.7 K |
| Sep 20 2016 | AGTC | APPLIED GENETIC TE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Buy | P | 8.75 | 10,000 | 87,500 | 10,000 | 0 to 10 K |
| Aug 30 2016 | AGTC | APPLIED GENETIC TE ... | Washer Susan B. | See Remarks | Option Exercise | M | 3.50 | 5,328 | 18,648 | 0 | |
| Aug 30 2016 | AGTC | APPLIED GENETIC TE ... | Washer Susan B. | See Remarks | Buy | M | 3.50 | 5,328 | 18,648 | 20,328 | 15 K to 20.3 K (+35.52 %) |
| Aug 18 2016 | AGTC | APPLIED GENETIC TE ... | VANLENT ANNE | Director | Option Exercise | A | 15.13 | 16,000 | 242,080 | 16,000 | |
| Jul 11 2016 | AGTC | APPLIED GENETIC TE ... | Chulay Jeffrey D. | See Remarks | Option Exercise | A | 15.57 | 35,000 | 544,950 | 35,000 | |
| Jul 11 2016 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Option Exercise | A | 15.57 | 50,000 | 778,500 | 50,000 | |
| Jul 11 2016 | AGTC | APPLIED GENETIC TE ... | Potter Stephen W | See Remarks | Option Exercise | A | 15.57 | 50,000 | 778,500 | 50,000 | |
| Jul 11 2016 | AGTC | APPLIED GENETIC TE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Option Exercise | A | 15.57 | 35,000 | 544,950 | 35,000 | |
| Jul 11 2016 | AGTC | APPLIED GENETIC TE ... | Washer Susan B. | See Remarks | Option Exercise | A | 15.57 | 80,000 | 1,245,600 | 80,000 | |
| May 26 2016 | AGTC | APPLIED GENETIC TE ... | Chulay Jeffrey D. | VP and Chief Medica ... | Option Exercise | M | 3.50 | 2,000 | 7,000 | 2,028 | |
| May 26 2016 | AGTC | APPLIED GENETIC TE ... | Chulay Jeffrey D. | VP and Chief Medica ... | Buy | M | 3.50 | 2,000 | 7,000 | 11,900 | 9.9 K to 11.9 K (+20.20 %) |
| May 26 2016 | AGTC | APPLIED GENETIC TE ... | Chulay Jeffrey D. | VP and Chief Medica ... | Option Exercise | M | 3.50 | 4,000 | 14,000 | 4,028 | |
| May 26 2016 | AGTC | APPLIED GENETIC TE ... | Chulay Jeffrey D. | VP and Chief Medica ... | Buy | M | 3.50 | 4,000 | 14,000 | 9,900 | 5.9 K to 9.9 K (+67.80 %) |
| Dec 04 2015 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Option Exercise | A | 16.06 | 6,200 | 99,572 | 6,200 | |
| Dec 04 2015 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Option Exercise | A | 16.06 | 6,200 | 99,572 | 6,200 | |
| Dec 04 2015 | AGTC | APPLIED GENETIC TE ... | Koenig Scott | Director | Option Exercise | A | 16.06 | 6,200 | 99,572 | 6,200 | |
| Dec 04 2015 | AGTC | APPLIED GENETIC TE ... | PEACOCK BRUCE | Director | Option Exercise | A | 16.06 | 6,200 | 99,572 | 6,200 | |
| Dec 04 2015 | AGTC | APPLIED GENETIC TE ... | Magovcevic Ivana | Director | Option Exercise | A | 16.06 | 6,200 | 99,572 | 6,200 | |
| Dec 04 2015 | AGTC | APPLIED GENETIC TE ... | HURWITZ EDWARD | Director | Option Exercise | A | 16.06 | 6,200 | 99,572 | 6,200 | |
| Sep 28 2015 | AGTC | APPLIED GENETIC TE ... | Magovcevic Ivana | Director | Option Exercise | A | 19.07 | 9,375 | 178,781 | 9,375 | |
| Jul 23 2015 | AGTC | APPLIED GENETIC TE ... | Chulay Jeffrey D. | See Remarks | Option Exercise | A | 18.48 | 71,000 | 1,312,080 | 71,000 |